Table 2.
Treatment cycle outcomes for PPCOS II participants who ovulated with tubal patency confirmed by SIS versus HSG and for all patients who ovulated
| Outcome | SIS N (%) |
HSG N (%) |
Another test or no test N (%) |
All patients N (%) |
P value* |
|---|---|---|---|---|---|
| N | 414 | 187 | 18 | 619 | |
| Conception | 160 (38.7) | 87 (46.5) | 10 (55.6) | 257 (41.5) | 0.069 |
| Clinical pregnancy | 123 (29.7) | 68 (36.4) | 7 (38.9) | 198 (32.0) | 0.105 |
| Pregnancy loss | 46 (11.1) | 28 (15.0) | 5 (27.8) | 79 (12.8) | 0.182 |
| First trimester lossa | 44 (10.6) | 25 (13.4) | 5 (27.8) | 74 (12.0) | 0.329 |
| Ectopicb | 3 (0.7) | 6 (3.2) | 1 (5.6) | 10 (1.6) | 0.029 |
| Live birth | 111 (26.8) | 59 (31.6) | 5 (27.8) | 175 (28.3) | 0.232 |
| Days to pregnancy | 86.7 ± 46.0 | 91.7 ± 46.8 | 98.0 ± 43.8 | 88.7 ± 46.1 | 0.436 |
Values are mean ± standard deviation or n (%)
*P value for significance of difference between SIS vs. HSG groups only
aPregnancy loss in the first 12 weeks
bIncludes seven ectopic pregnancies, one heterotopic pregnancy, and two pregnancies of unknown location